{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470619490
| IUPAC_name = (6α,11β,16β)-21-chloro-6,9-difluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
| image = Ulobetasol.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|ulobetasol}}
| MedlinePlus = a601060
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_UK = <!-- GSL         / P       / POM / CD -->
| legal_US = <!-- OTC                   / Rx-only  -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 98651-66-2
| ATC_prefix = D07
| ATC_suffix = AC21
| PubChem = 5311167
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4470691
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9P6159HM7T
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08660
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201360

<!--Chemical data-->
| C=22 | H=27 | Cl=1 | F=2 | O=4 
| molecular_weight = 428.897
| smiles = ClCC(=O)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)[C@@H](F)C[C@H]4[C@@H]2C[C@@H]3C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H27ClF2O4/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13-,14-,16-,17-,19-,20-,21-,22-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LEHFPXVYPMWYQD-XHIJKXOTSA-N
| synonyms = <small>(6''S'',8''S'',9''S'',10''S'',11''S'',13''S'',14''S'',16''S'',17''R'')-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[''a'']phenanthren-3-one</small>
}}

'''Ulobetasol''' ([[International Nonproprietary Name|INN]]) or '''halobetasol''' ([[United States Adopted Name|USAN]]) is a [[corticosteroid]] used to treat [[psoriasis]]. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream. Halobetasol is the strongest topical steroid available.{{cn|date=February 2017}}

==External links==
* {{MeshName|halobetasol}}


{{Glucocorticoids}}
{{Glucocorticoidics}}

[[Category:Glucocorticoids]]
[[Category:Organofluorides]]
[[Category:Organochlorides]]
[[Category:Alcohols]]
[[Category:Ketones]]
[[Category:Halohydrins]]


{{dermatologic-drug-stub}}